Back to News
Market Impact: 0.12

Correction: Zealand Pharma - Transactions related to share buy-back program (week 35, 2026)

Source: globenewswire.com

Capital Returns (Dividends / Buybacks)Company Fundamentals
Correction: Zealand Pharma - Transactions related to share buy-back program (week 35, 2026)

Zealand Pharma (Nasdaq: ZEAL) issued a correction related to its share buy-back program, covering transactions for week 35 of 2026. The announcement is administrative and does not indicate a change in the underlying buyback pace or broader operating outlook. Net impact on the stock is likely limited.

AllMind Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Trial

Market Sentiment

Overall Sentiment

neutral

Sentiment Score

0.05

Ticker Sentiment

ZLDPF0.00

More News